Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Cronos Australia Ltd. ( (AU:VIT) ) is now available.
Vitura Health Limited has completed the acquisition of the Canview platform from Code4 Cannabis Pty Ltd, allowing it to fully control and develop the platform. This acquisition is expected to enhance Vitura’s technological capabilities and reduce costs, aligning with its strategic goals. The company has issued shares and made cash payments as part of the settlement, and will withdraw legal proceedings against C4C. This move strengthens Vitura’s position in the digital health industry and supports its growth strategy.
More about Cronos Australia Ltd.
Vitura Health Limited is a diversified digital health business listed on the ASX, focusing on creating a centralized healthcare experience through its subsidiaries. The company operates several platforms, including Canview, a comprehensive healthcare ecosystem for medicinal cannabis distribution, and Doctors on Demand, a telehealth service. Vitura is also involved in distributing psychedelic products and owns stakes in various healthcare-related ventures.
YTD Price Performance: 20.73%
Average Trading Volume: 417,791
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$64.99M
Learn more about VIT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue